Statistics from Altmetric.com
Colleagues, I am writing to update you on the productivity of the Journal of Investigative Medicine (JIM) in 2021. I am very happy to report that indeed it was a banner year for the journal, as evidenced by a 17% increase in submissions compared with 2020 and a 17% increase in acceptances—both continuing the upward curve that began in 2020 (figure 1). This suggests that, during this COVID-19 pandemic, investigators found the time to update and finalize their data and complete manuscripts that may have been sitting on their desks for some time. With less opportunity to travel, attend meetings, and present abstracts in person, authors also may have chosen to expedite publication of their work.
The overall acceptance rate for original research was 27% and for all submissions the acceptance rate was 33%. The instant rejection rate increased from 28% in 2020 to 40%.
The time to first decision on all submissions averaged 1 month and the time to first decision for reviewed …
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.